JPRN-UMIN000002491尚未招募2 期
Multicenter study about an effect of Vinorelbine for recurrent brteast cancer - Naberubine study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •poor prognoses and poor PS
研究者
相似试验
进行中（未招募）
1 期
A Randomised Phase II study of Oral Vinorelbine or I.V. Vinorelbine in patients with metastatic breast cancer previously treated with anthracyclinesTreatment in metastatic breast cancer previously treated with anthracyclinesEUCTR2004-000963-81-BEPierre Fabre Medicament230
进行中（未招募）
不适用
A Randomised Phase II study of Oral Vinorelbine or I.V. Vinorelbine in patients with metastatic breast cancer previously treated with anthracyclinesTreatment in metastatic breast cancer previously treated with anthracyclinesEUCTR2004-000963-81-ATRobapharm AG230
招募中
2 期
Treatment of ectopic pregnancies of participants with vinorelbine tablets.Reproductive Health and Childbirth - Other reproductive health and childbirth disordersECTOPIC PREGNANCYACTRN12617001118392orth Shore Hospital20
已完成
不适用
Randomised phase II trial comparing vinorelbine and capecitabine with docetaxel and capecitabine chemotherapy for metastatic breast cancerBreastCancerBreast cancerISRCTN66842537Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)100
已完成
2 期
Meinetenance chemotherapy in lung cancerMalignant neoplasm of lung and brochous.Malignant neoplasm of bronchus and lung including: main bronchus, upper lobe bronchus , Middle lobe bronchus, Lower lobe, bronchus or Bronchus or lung, unspecified.code:C34IRCT2015060822610N1Investigator100